Virphysio Medtech CO., LTD.
Update：2026/03/18
Industries
Main Industry
Health Care
Main Product/Service
Leveraging digital twin and artificial intelligence technologies to innovate cardiac care by developing programmable and personalized treatment plans.
Founded Year
2025
Unified Business No.
96769710
Status
Active
Number of Employees
0
Total Paid-in
Capital
3,310,000 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Through a programmable treatment framework based on digital twins and artificial intelligence, healthcare is transformed from reactive care to proactive prevention. By integrating non-invasive imaging, functional assessment, and intelligent decision support, Weili Biomedical empowers clinicians to predict outcomes, personalize care, and develop optimal treatment plans for each patient.
